Furthermore, FBXW7 negatively regulates CRY2 via a ubiquitin-dependent pathway and potentiates chemosensitivity of CRC cells, which proposes the method to enhance the antitumor efficacy targeting clock proteins (225). This evidence concerns the gene CLOCK and colorectal carcinoma.